Search

Search Results
Results 1 - 10 of 17 for Targeted drug delivery
  • Targeting Protein Misfolding Congress 2021
    Supplier - 7 Dec 2020
    With the neurological drug market now worth $86 billion, and the FDA set to reach a decision on Biogen’s Acudanimib in Spring, whether you’re focused on oncology, Alzheimer’s or ALS, it’s an exciting...
  • GenScript
    Supplier - 13 Nov 2018
    Genscript is the world’s leading biotech company providing life sciences services and products. With gene synthesis, peptide, protein, antibody and preclinical drug development service capabilities,...
  • B. Braun Melsungen AG
    Supplier - 30 Nov 2012
    B. Braun is one of the world's leading providers and manufacturers of healthcare solutions today. Every service that B. Braun provides incorporates the entirety of our knowledge and skills, the...
  • Blood-Brain Barrier Delivery Summit (B3DD)
    Supplier - 17 Jun 2019
    B3DD is a conference dedicated to addressing the translational challenges of effective and safe delivery of CNS drug candidates that cross the blood-brain barrier.
  • Orbit Discovery
    Supplier - 14 Jun 2022
    Orbit develop and apply innovative drug discovery platforms defined by a unique peptide display engine that deliver novel, functional, biologically relevant peptide therapeutic leads.
  • Sino Biological Inc.
    Supplier - 11 Mar 2021
    Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development.
  • Ubiquigent Limited
    Supplier - 23 Jan 2023
    As pioneers in the rapidly emerging deubiquitinase (DUB) space, Ubiquigent™ is uniquely positioned to drive forward the discovery and development of novel DUB modulators as powerful new therapeutics...
  • Neurodegenerative Drug Development
    Supplier - 4 Apr 2019
    Focused on neurodegenerative disease, the drug development community will assemble at NDD Europe to overcome the translational challenges blocking the development of clinically disease modifying...
  • Neuroimmunology Drug Development
    Supplier - 4 Apr 2019
    As drug developers are investing time and money into exploring chronic neuroinflammatory targets, it is essential for the right investments to be made.
  • Next Generation Lipid-Based Nanoparticles Delivery Summit
    Supplier - 31 May 2022
    After 2 decades of research, lipid-based nanoparticles have finally become clinically viable delivery vehicle following advanced technologies. The success of mRNA vaccines is merely touching the tip...

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback